iShares Healthcare Innovation UCITS ETFiShares Healthcare Innovation UCITS ETFiShares Healthcare Innovation UCITS ETF

iShares Healthcare Innovation UCITS ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪798.37 M‬EUR
Fund flows (1Y)
‪−132.35 M‬EUR
Dividend yield (indicated)
Discount/Premium to NAV
0.9%
Shares outstanding
‪107.68 M‬
Expense ratio
0.40%

About iShares Healthcare Innovation UCITS ETF


Brand
iShares
Home page
Inception date
Sep 8, 2016
Structure
Irish VCIC
Index tracked
STOXX Global Breakthrough Healthcare (USD)(NR)
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
BlackRock Asset Management Ireland Ltd.
ISIN
IE00BYZK4776
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the STOXX Global Breakthrough Healthcare Index

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
ESG
Geography
Global
Weighting scheme
Equal
Selection criteria
Principles-based
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
1%62%25%10%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Broaden your horizons with more funds linked to 2B78 via country, focus, and more.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
2B78 trades at 6.444 EUR today, its price has risen 0.03% in the past 24 hours. Track more dynamics on 2B78 price chart.
2B78 net asset value is 6.48 today — it's risen 6.43% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
2B78 assets under management is ‪798.37 M‬ EUR. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
2B78 price has risen by 2.42% over the last month, and its yearly performance shows a −8.48% decrease. See more dynamics on 2B78 price chart.
NAV returns, another gauge of an ETF dynamics, showed a −14.09% decrease in three-month performance and has decreased by −8.01% in a year.
2B78 fund flows account for ‪−132.35 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
2B78 invests in stocks. See more details in our Analysis section.
2B78 expense ratio is 0.40%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, 2B78 isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, 2B78 technical analysis shows the sell rating and its 1-week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating 2B78 shows the strong sell signal. See more of 2B78 technicals for a more comprehensive analysis.
No, 2B78 doesn't pay dividends to its holders.
2B78 trades at a premium (0.89%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
2B78 shares are issued by BlackRock, Inc.
2B78 follows the STOXX Global Breakthrough Healthcare (USD)(NR). ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Sep 8, 2016.
The fund's management style is passive, meaning it's aiming to replicate the performance of the underlying index by holding assets in the same proportions as the index. The goal is to match the index's returns.